Accepted for Publication: March 25, 2013.
Published Online: September 23, 2013. doi:10.1001/jamapediatrics.2013.2698.
Study concept and design: King, Dukes, Sikich, McCracken, Scahill, Hollander, Anagnostou, Hirtz.
Acquisition of data: King, Donnelly, Sikich, McCracken, Scahill, Hollander, Bregman, Anagnostou.
Analysis and interpretation of data: King, Dukes, Sikich, McCracken, Scahill, Hollander, Bregman, Anagnostou, Robinson, Sullivan, Hirtz.
Drafting of the manuscript: King, Dukes, Hollander, Robinson.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Dukes, Robinson, Sullivan.
Obtained funding: King, Sikich, McCracken, Scahill, Hollander.
Administrative, technical, or material support: King, Dukes, Donnelly, McCracken, Scahill, Hollander, Bregman, Robinson, Hirtz.
Study supervision: King, Dukes, Donnelly, McCracken, Scahill, Robinson.
Conflict of Interest Disclosures: Dr Sikich has received research funding in the past 5 years from or participates in clinical trials sponsored by the National Institute of Mental Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Autism Speaks, the Foundation of Hope, Bristol Myers-Squibb, Curemark, Merck, Forest, Otsuka Research Institute, SynapDx, and Seaside Pharmaceuticals, and received software for a computer intervention in schizophrenia from Posit Science. She serves on the data and safety monitoring boards for the National Institute of Child Health and Human Development Rare Disease Network and Research Foundation for Mental Hygiene. In the past, she has received research funding from Eli Lilly, Janssen, Pfizer, Otsuka, AstraZeneca, and Neuropharm and has served as a consultant to sanofi aventis (2008) and ABT Associates (2008). No other disclosures were reported.
Funding/Support: This work was funded by the National Institute of Mental Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke, the National Institute on Deafness and Other Communication Disorders, and the National Institute of Environmental Health Sciences via the following STAART Center contracts: Boston University/Dartmouth (U54-MH066398), Helen Tager-Flusberg, principal investigator (PI); DM-STAT, Inc (U01-HD045023), Kimberly Dukes, PI; Mount Sinai (U54-MH066673), Eric Hollander, PI; UCLA (U54-MH068172), Marian Sigman, PI; University of North Carolina (U54-MH066418), Joseph Piven, PI; and Yale University (U54-MH066494), Fred Volkmar, PI.
Role of the Sponsor: The funding agency had a role in the design and supervision of the conduct of the study; in the collection, management, analysis, and interpretation of the data; and in the preparation and approval of the manuscript.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official position of the National Institute of Neurological Diseases and Stroke, the National Institutes of Health, or any other part of the US Department of Health and Human Services.
Additional Contributions: Research staff in the STAART psychopharmacology network included Rosemary Affeldt, MSW, LICSW, Denisse Ambler, MD, George Anderson, PhD, May-Lynn Andresen, RN, Grace Baranek, PhD, Jennifer Bartz, PhD, Karen Bearss, PhD, Terrence C. Bethea, MD, Jennifer Cowen, MA, Pegeen Cronin, PhD, Margaret DeRamus, BA, Robert Dimino, PhD, Ty Ellison, PhD, Lilia Fenelon, BA, Anita Gordon, MSW, Danielle Halpern, PhD, Marisa B. Houser, MS, Cathy Jones, BA, Paul Kartheiser, MD, Robyn Keske, MSW, MPH, Young Shin Kim, MD, PhD, Kathy Koenig, MSN, Erin Kustan, BA, Kathleen Lapp, MD, Arthur Maerlender, PhD, Joe Massaro, PhD, Brenna McDonald, PsyD, MBA, Debra McQuade, PhD, MD, Shana Nichols, PhD, Roumen Nikolov, MD, Maryellen Pachler, MSN, Yann Poncin, MD, Idania Ramirez, MPH, Jennifer Richards, MD, Peter Robichaux, BA, Jade Rusoff, BA, Bhavik Shah, MD, Latha Soorya, PhD, Linda Spritzer, BA, Erika Swanson, MA, John Vidaver, MA, Shula Waldoks, BA, Ting Wang, PhD, Stacey Wasserman, MD, and Emily Williams, MEd.